EGFR MUTATION

Clinical trials for EGFR MUTATION explained in plain language.

Never miss a new study

Get alerted when new EGFR MUTATION trials appear

Sign up with your email to follow new studies for EGFR MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 2 Not yet finished but already full! 2 Completed 1

New drug trial targets lung cancer in the brain

Disease control Completed

This study tested an oral drug called furmonertinib in patients with advanced non-small cell lung cancer (NSCLC) that had spread to the brain. The goal was to see how well the drug controlled the cancer in the brain and body, and how safe it was. It specifically enrolled 24 patie…

Matched conditions: EGFR MUTATION

Phase: PHASE2 • Sponsor: Peking Union Medical College • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC

EGFR MUTATION

Get alerted when new EGFR MUTATION trials appear

New drug trial targets lung cancer in the brain